| |
| |
A Word About This Guide | |
| |
| |
Contributors to the Seventh Edition | |
| |
| |
Acknowledgments | |
| |
| |
Diagnosis and Classification | |
| |
| |
Highlights | |
| |
| |
Definition of Diabetes | |
| |
| |
Diagnosis of Diabetes | |
| |
| |
Classification of Diabetes | |
| |
| |
Type 1 diabetes | |
| |
| |
Type 2 diabetes | |
| |
| |
Other specific types of diabetes | |
| |
| |
Stage of disease | |
| |
| |
Screening for Diabetes | |
| |
| |
Categories of Increased Risk for Diabetes | |
| |
| |
Gestational Diabetes Mellitus | |
| |
| |
Metabolic Syndrome | |
| |
| |
Evaluation and Classification of Patients Before Treatment | |
| |
| |
Pathogenesis | |
| |
| |
Highlights | |
| |
| |
Genetic and Environmental Factors | |
| |
| |
Insulin Resistance | |
| |
| |
Sites of insulin resistance | |
| |
| |
Mechanisms of insulin resistance | |
| |
| |
The Fat Cell as an Endocrine Organ | |
| |
| |
Defects in Insulin Secretion | |
| |
| |
Factors modulating insulin secretion | |
| |
| |
Physiological consequences of defective insulin secretion | |
| |
| |
Conclusion | |
| |
| |
Management | |
| |
| |
Highlights | |
| |
| |
Therapeutic Objectives and Plan | |
| |
| |
MNT Effectiveness, Process, and Goals | |
| |
| |
Energy balance and weight loss | |
| |
| |
Carbohydrate | |
| |
| |
Protein | |
| |
| |
Fat | |
| |
| |
Sodium | |
| |
| |
Alcohol | |
| |
| |
Vitamins and minerals | |
| |
| |
Exercise | |
| |
| |
Potential benefits of exercise | |
| |
| |
Precautions and considerations | |
| |
| |
The exercise prescription | |
| |
| |
Pharmacologic Intervention | |
| |
| |
Available agents | |
| |
| |
Insulins | |
| |
| |
Long-term combinations of oral agents with insulin | |
| |
| |
Adjusting insulin dosage in long-term type 2 diabetes | |
| |
| |
Assessment of Treatment Efficacy | |
| |
| |
Office methods | |
| |
| |
Self-monitoring | |
| |
| |
Special Therapeutic Situations | |
| |
| |
Highlights | |
| |
| |
Diabetes in Pregnancy | |
| |
| |
Diabetes in Youth | |
| |
| |
Differentiation of type 1 and type 2 diabetes in youth | |
| |
| |
Screening for type 2 diabetes in youth | |
| |
| |
Treating type 2 diabetes in youth | |
| |
| |
Diabetes in Hospitalized and Critically Ill Patients | |
| |
| |
Major Acute Complications | |
| |
| |
Hyperosmolar hyperglycemic state | |
| |
| |
Hypoglycemia | |
| |
| |
Infection | |
| |
| |
Detection and Treatment of Chronic Complications | |
| |
| |
Highlights | |
| |
| |
Rationale for Optimizing Glycemic Control in Type 2 Diabetes | |
| |
| |
Accelerated Macrovascular Disease | |
| |
| |
Diabetes as a cardiovascular risk factor | |
| |
| |
Screening for cardiovascular disease | |
| |
| |
Importance of modifying vascular risk factors | |
| |
| |
Treatment of cardiovascular disease | |
| |
| |
Diabetic Retinopathy | |
| |
| |
Stages of diabetic retinopathy | |
| |
| |
Prevention of vision loss from retinopathy | |
| |
| |
Treatment of retinopathy | |
| |
| |
Diabetic Renal Disease | |
| |
| |
Clinical presentation of nephropathy | |
| |
| |
Conditions that influence renal function | |
| |
| |
Prevention and treatment of diabetic renal disease | |
| |
| |
Diabetic Foot Problems | |
| |
| |
Causes of diabetic foot problems | |
| |
| |
Prevention of foot problems | |
| |
| |
Treatment of foot problems | |
| |
| |
Diabetic Neuropathies | |
| |
| |
Diagnosis and treatment of neuropathy | |
| |
| |
Autonomic neuropathy | |
| |
| |
Other varieties of diabetic neuropathy | |
| |
| |
Behavior Change Strategies | |
| |
| |
Highlights | |
| |
| |
Influences on Behavior Change | |
| |
| |
Strategies for Behavior Change | |
| |
| |
Diabetes Self-Management Support | |
| |
| |
Redesigning Practice to Support Behavior Change | |
| |
| |
Summary | |
| |
| |
Index | |